No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
CSLLY CSL LTD SPON ADR EACH REPR 0.5 ORD
- 90.160
- +0.060+0.07%
15min DelayClose Apr 25 16:00 ET
87.14BMarket Cap35.43P/E (TTM)
90.240High88.880Low30.38KVolume89.350Open90.100Pre Close2.72MTurnover0.00%Turnover Ratio39.81P/E (Static)966.51MShares103.65752wk High5.07P/B87.14BFloat Cap71.05852wk Low1.18Dividend TTM966.51MShs Float113.800Historical High1.31%Div YieldTTM1.51%Amplitude71.058Historical Low89.682Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Travere, CSL Win Conditional Nod for Kidney Disease Therapy in EU
CureVac Posts Early Efficacy Results for GSK-partnered Flu Shot
Akebia Stock Jumps as FDA Clears Renal Anemia Therapy
Kyowa Kirin's Rare Disease Therapy Becomes World's Most Expensive Drug
Ferinject Approved by Health Canada for the Treatment of Iron Deficiency Anemia in Adult...
CSL Ltd's Dividend Analysis
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg